PTrana Meditama Metropolitan Tbk (ISX:SAME) Cyclically Adjusted Revenue per Share: Rp103.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SAME PT Sarana Meditama Metropolitan Tbk ISX:SAME
65 GF Score
Price Rp320.00
GF Value Rp354.65
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PTrana Meditama Metropolitan Tbk Cyclically Adjusted Revenue per Share?

PTrana Meditama Metropolitan Tbk ISX:SAME +3.90% 65 Cyclically Adjusted Revenue per Share is Rp103.25 as of Jun. 2026. GuruFocus rates ISX:SAME with a GF Score™ of 65/100 and a GF Value™ of Rp354.65 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PTrana Meditama Metropolitan Tbk's adjusted revenue per share for the three months ended in Jun. 2026 was Rp29.756. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is Rp103.25 for the trailing ten years ended in Jun. 2026.

During the past 12 months, PTrana Meditama Metropolitan Tbk's average Cyclically Adjusted Revenue Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-01), PTrana Meditama Metropolitan Tbk's current stock price is Rp320.00. PTrana Meditama Metropolitan Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was Rp103.25. PTrana Meditama Metropolitan Tbk's Cyclically Adjusted PS Ratio of today is 3.10.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PTrana Meditama Metropolitan Tbk was 4.31. The lowest was 2.42. And the median was 3.18.


PTrana Meditama Metropolitan Tbk  (ISX:SAME) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PTrana Meditama Metropolitan Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=320.00/103.25
=3.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PTrana Meditama Metropolitan Tbk was 4.31. The lowest was 2.42. And the median was 3.18.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PTrana Meditama Metropolitan Tbk Cyclically Adjusted Revenue per Share Related Terms


PTrana Meditama Metropolitan Tbk Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PTrana Meditama Metropolitan Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PTrana Meditama Metropolitan Tbk Cyclically Adjusted Revenue per Share Chart

PTrana Meditama Metropolitan Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 89.09 94.16 100.24

PTrana Meditama Metropolitan Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.93 98.37 100.24 101.87 103.25

ISX:SAME vs HCA, THC, EHC: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PTrana Meditama Metropolitan Tbk Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PTrana Meditama Metropolitan Tbk's Cyclically Adjusted PS Ratio falls into.


ISX:SAME
65GF Score
PT Sarana Meditama Metropolitan Tbk ISX:SAME
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PTrana Meditama Metropolitan Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PTrana Meditama Metropolitan Tbk's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.756/137.6954*137.6954
=29.756

Current CPI (Jun. 2026) = 137.6954.

PTrana Meditama Metropolitan Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 18.101 104.142 23.933
201612 17.674 105.222 23.129
201703 19.965 106.476 25.819
201706 20.810 107.722 26.600
201709 22.102 108.020 28.174
201712 22.673 109.017 28.637
201803 24.535 110.097 30.685
201806 24.848 111.085 30.800
201809 27.105 111.135 33.583
201812 28.534 112.430 34.946
201903 30.328 112.829 37.012
201906 27.283 114.730 32.744
201909 -13.930 114.905 -16.693
201912 14.706 115.486 17.534
202003 20.447 116.252 24.219
202006 6.904 116.630 8.151
202009 30.306 116.397 35.852
202012 36.005 117.318 42.259
202103 24.291 117.840 28.384
202106 23.545 118.184 27.432
202109 19.793 118.262 23.046
202112 16.617 119.516 19.145
202203 25.803 120.948 29.376
202206 16.839 123.322 18.802
202209 22.177 125.298 24.371
202212 21.935 126.098 23.952
202303 21.273 126.953 23.073
202306 20.875 127.663 22.515
202309 23.592 128.151 25.349
202312 23.608 129.395 25.122
202403 25.260 130.607 26.631
202406 24.172 130.792 25.448
202409 25.290 130.361 26.713
202412 24.790 131.432 25.971
202503 25.696 131.948 26.815
202506 25.305 133.241 26.151
202509 28.692 133.819 29.523
202512 28.832 135.271 29.349
202603 27.910 136.539 28.146
202606 29.756 137.695 29.756

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of Rp103.25 mean?
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Cyclically Adjusted Revenue per Share of Rp103.25 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PTrana Meditama Metropolitan Tbk and its competitors.
Is PTrana Meditama Metropolitan Tbk's Cyclically Adjusted Revenue per Share too high?
PTrana Meditama Metropolitan Tbk's current Cyclically Adjusted Revenue per Share is Rp103.25. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Cyclically Adjusted Revenue per Share compare to HCA and THC?
PTrana Meditama Metropolitan Tbk's Cyclically Adjusted Revenue per Share of Rp103.25 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. PTrana Meditama Metropolitan Tbk's current Cyclically Adjusted Revenue per Share is Rp103.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp354.65, compared to a current price of Rp320.00 — trading 9.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is Rp103.25. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Cyclically Adjusted Revenue per Share is Rp103.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?

Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued. The current stock price of Rp320.00 is trading 9.8% below its estimated GF Value™ of Rp354.65. GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.

Key valuation signals for ISX:SAME:

  • Cyclically Adjusted Revenue per Share: Rp103.25
  • GF Value™: Rp354.65 vs. price of Rp320.00 (9.8% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PTrana Meditama Metropolitan Tbk Business Description

Address Jalan Pulomas Barat VI No. 20, RS EMC Pulomas, Kayu Putih, Pulogadung, Jakarta Timur, Jakarta, IDN, 13210
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
65GF Score

Get the complete analysis for ISX:SAME

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp320.00
Price
Rp354.65
GF Value